Catalyst Pharmaceuticals Inc (CPRX)
21.48
+0.36
(+1.70%)
USD |
NASDAQ |
Nov 22, 16:00
21.47
-0.01
(-0.05%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap: 2.562B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.562B |
| November 21, 2024 | 2.519B |
| November 20, 2024 | 2.523B |
| November 19, 2024 | 2.551B |
| November 18, 2024 | 2.483B |
| November 15, 2024 | 2.457B |
| November 14, 2024 | 2.587B |
| November 13, 2024 | 2.719B |
| November 12, 2024 | 2.748B |
| November 11, 2024 | 2.797B |
| November 08, 2024 | 2.854B |
| November 07, 2024 | 2.773B |
| November 06, 2024 | 2.709B |
| November 05, 2024 | 2.619B |
| November 04, 2024 | 2.594B |
| November 01, 2024 | 2.611B |
| October 31, 2024 | 2.600B |
| October 30, 2024 | 2.571B |
| October 29, 2024 | 2.596B |
| October 28, 2024 | 2.607B |
| October 25, 2024 | 2.559B |
| October 24, 2024 | 2.553B |
| October 23, 2024 | 2.545B |
| October 22, 2024 | 2.559B |
| October 21, 2024 | 2.507B |
| Date | Value |
|---|---|
| October 18, 2024 | 2.533B |
| October 17, 2024 | 2.524B |
| October 16, 2024 | 2.585B |
| October 15, 2024 | 2.526B |
| October 14, 2024 | 2.462B |
| October 11, 2024 | 2.409B |
| October 10, 2024 | 2.375B |
| October 09, 2024 | 2.382B |
| October 08, 2024 | 2.395B |
| October 07, 2024 | 2.353B |
| October 04, 2024 | 2.385B |
| October 03, 2024 | 2.371B |
| October 02, 2024 | 2.385B |
| October 01, 2024 | 2.412B |
| September 30, 2024 | 2.371B |
| September 27, 2024 | 2.322B |
| September 26, 2024 | 2.368B |
| September 25, 2024 | 2.374B |
| September 24, 2024 | 2.433B |
| September 23, 2024 | 2.432B |
| September 20, 2024 | 2.468B |
| September 19, 2024 | 2.534B |
| September 18, 2024 | 2.425B |
| September 17, 2024 | 2.426B |
| September 16, 2024 | 2.426B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
269.90M
Minimum
Mar 16 2020
2.854B
Maximum
Nov 08 2024
1.090B
Average
807.38M
Median
Market Cap Benchmarks
| Corcept Therapeutics Inc | 6.029B |
| Vertex Pharmaceuticals Inc | 116.14B |
| Sarepta Therapeutics Inc | 10.91B |
| ADMA Biologics Inc | 5.007B |
| BioVie Inc | 54.19M |
Market Cap Related Metrics
| PE Ratio | 18.20 |
| PS Ratio | 5.682 |
| PEG Ratio | 0.1434 |
| Price to Book Value | 3.876 |
| Price to Free Cash Flow | 11.80 |
| Price | 21.48 |
| Earnings Yield | 5.49% |
| PEGY Ratio | 0.1434 |
| Operating PE Ratio | 15.04 |
| Normalized PE Ratio | 18.16 |